NL-OMON56782
Not yet recruiting
Not Applicable
Intensification of treatment in people with an obsessive compulsive disorder who do not recover sufficiently from regular ERP treatment: a stepped care approach - FOCUS after regular CBT for OCD
HSK Groep0 sites35 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Obsessive compulsive disorder
- Sponsor
- HSK Groep
- Enrollment
- 35
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Participants have a current primary classification of obsessive compulsive
- •disorderd according to the DSM\-5, assessed with the DSI.
- •Participants have a Y\-BOCS score of 16 or higher
- •Participants have a SQ\-48 score higher than 37
- •Participants have an age between 18\-64 years
- •Participants are able to speak the Dutch language on a sufficient level
Exclusion Criteria
- •\- Presence of severe developmental disorders
- •\- Severe suicidality
- •\- Presence of a acute psychotic disorder
- •\- Presence of a disorder that interferes with OCD
- •\- Personalitytraits or disorders that need treatment first
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
sing two drugs in combination at the start of drug treatment for type 2 diabetes vs using a single drugISRCTN26805203Pakistan Institute of Medical Sciences285
Recruiting
Phase 1
Intensified treatment in patients with oligometastatic pancreatic cancer - multimodal surgical treatment versus systemic chemotherapy alone: a randomized controlled trial - METAPANColigometastatic pancreatic cancerTherapeutic area: Analytical,Diagnostic,Therapeutic Techniques and Equipment [E]-Surgical Procedures, Operative [E04]Therapeutic area: Diseases [C] - Neoplasms [C04]CTIS2023-503558-10-00niversitaetsmedizin Goettingen425
Completed
Not Applicable
Impact of comprehensive and intensive treatment of risk factors concerning cardiovascular mortality in secondary prevention: MIRVAS studySecondary prevention of cardiovascular diseaseCirculatory SystemISRCTN93700442a Princesa University Hospital (Hospital Universitario de La Princesa) (Spain)247
Recruiting
Phase 1
CAR-T-cell treatment for untreated high risk MANtle Cell LymphomaMantle Cell Lymphoma (MCL)MedDRA version: 21.0Level: PTClassification code: 10026805Term: Mantle cell lymphoma stage IV Class: 100000004864MedDRA version: 21.0Level: PTClassification code: 10026803Term: Mantle cell lymphoma stage II Class: 100000004864MedDRA version: 21.0Level: PTClassification code: 10026804Term: Mantle cell lymphoma stage III Class: 100000004864Therapeutic area: Diseases [C] - Neoplasms [C04]CTIS2022-502405-15-01Klinikum Der Universitat Munchen AöR91
Active, not recruiting
Not Applicable
HEMOS ALL 0105 Intensification therapy of mature B-ALL, Burkitt and Burkitt like and other HIgh Grade Non-Hodgkin?s Lymphoma in Adults - HEMOS ALL 1105B-ALL, Burkitt and Burkitt likeand Non-Hodgkin?s Lymphoma in AdultsMedDRA version: 9.1Level: LLTClassification code 10006595Term: Burkitt's lymphomaEUCTR2006-006154-97-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI